Small-cap resources led the week’s biggest moves, but sharp falls in Bounty Oil and Nyrada showed how quickly investors can sell when funding and deal terms remain uncertain.
Gold, copper, rare earths and takeover activity supplied the strongest gains, while several companies still need more cash before they can deliver their plans.
- Bounty Oil & Gas fell 36.84% after announcing a conditional Liberia deal that could issue more than 1.3 billion shares.
- Waratah Minerals rose 29.27% after drilling returned 46 metres at 7.27 grams of gold per tonne.
- Nyrada dropped 28.77% despite raising A$12 million to fund its heart-treatment trial.
- Resources companies dominated the leaders, with copper, gold and critical-mineral discoveries driving buying.
- Takeover activity remained active across media, healthcare, travel, property and biotechnology.
Small-cap explorers delivered the week’s biggest gains and losses. Bounty Oil & Gas NL (ASX:BUY) fell -36.84% after agreeing to buy a Liberian deepwater block without a signed production contract or an independent resource estimate. The deal could also create more than 1.3 billion new shares. Waratah Minerals (ASX:WTM) rose 29.27% after drilling found 46 metres at 7.27 grams of gold per tonne. Nyrada (ASX:NYR) dropped -28.77% after raising A$12 million, as investors focused on dilution and the cost of its clinical trial.
Resources drive the largest moves
Waratah’s result extended gold mineralisation at its Spur discovery. A narrower section graded 10 metres at 28.93 grams per tonne, including 1.3 metres at 206 grams. The company has not yet published a formal resource, so the next drilling results must show that the high grades continue.
BOA Resources (ASX:BOA) gained 26.51% after all six first-pass drill holes at Ricci Lee found copper. The best results included 14 metres at 2.49% copper and 15 metres at 2.25%. Investors now await assays from another 40 reverse-circulation holes and 92 aircore holes.
At the other end, Bounty’s share price fell because its Liberian project remains conditional. The company must still negotiate a production contract and receive parliamentary approval. It also plans to issue performance shares linked to future resources and farm-outs. After reopening at 0.024, the stock fell a further 50%. That is an air pocket: early selling continued instead of settling.
Gold and copper plans grow, but cash remains important
AIC Mines (ASX:A1M) rose 12.50% after agreeing to buy the Mt Cuthbert copper project for A$120 million. The project contains 246,000 tonnes of copper in its reported resource, but it has no Ore Reserve. That means the company has not yet proved how much metal can be mined profitably.
Ramelius Resources (ASX:RMS) added 8.10% after lifting its FY30 production target to as much as 610,000 ounces. It plans up to A$570 million of growth spending in FY27. The larger Mt Magnet plant must now be built on time and within budget.
Several smaller developers also reported strong project studies but limited cash. Australian Rare Earths (ASX:AR3) has a proposed Koppamurra project with an after-tax study value of A$858 million, yet held only A$4.4 million and warned that more money is needed. Globe Metals and Mining (ASX:GBE) reported a US$1.025 billion study value for Kanyika, but had A$2.78 million in cash. For both companies, attracting finance is now as important as proving the geology.
Deals reshape several sectors
IVE Group (ASX:IGL) agreed to buy Motio for about A$20.7 million, adding more than 1,300 digital screens. Motio (ASX:MXO) rose 13.46% after accepting the six-cent cash offer. Completion still needs shareholder and Court approval.
Telix Pharmaceuticals (ASX:TLX) fell -10.92% after announcing its US$1.65 billion purchase of ITM. The deal would give Telix more control over radioactive materials used in cancer treatment. Investors also face share dilution, integration work and an unresolved US regulatory review of ITM-11. Since reopening at 17.1, Telix has fallen 7.02%.
Other transactions included Helloworld Travel’s A$135 million purchase of Crown Currency Exchange and a proposed merger between Microba Life Sciences and Genetic Signatures. IDP Education (ASX:IEL) rejected Blackstone’s improved A$2.50 offer, leaving investors to judge whether a higher bid will appear.
Capital raises bring support and pressure
Nyrada’s A$12 million placement will fund its Xolatryp heart-treatment programme through key trial data. The company also proposed a A$2 million share purchase plan and a large director subscription. Investors sold the stock because the new shares reduce existing holders’ ownership, while the trial can still fail.
Wildcat Resources (ASX:WC8) fell -14.71% after raising A$60 million for its Tabba Tabba lithium project. The cash supports engineering and site work, but shareholders must still approve part of the issue. The share price has fallen 7.94% since reopening at 0.315.
Silver Mines (ASX:SVL) also fell -17.14% after announcing a A$70 million placement for Bowdens. The company will use some of the money to buy back royalties. The raise may simplify the project, but it creates 482.8 million new shares. Since reopening at 0.16, the stock has fallen 9.38%.
The week also brought clear operating progress. Bannerman Energy (ASX:BMN) completed the CNOL investment for Etango, giving the uranium joint venture about US$303 million in cash. Core Lithium (ASX:CXO) produced its first spodumene concentrate at Finniss, while Larvotto Resources (ASX:LRV) produced its first gold and antimony concentrate at Hillgrove. These milestones reduce uncertainty, but both companies still need to increase production and control costs.
Financial statements supplied a more cautious message. Rua Bioscience (ASX:RUA) grew customer revenue by 71%, but its auditor warned that more capital may be needed. HealthCo Healthcare and Wellness REIT (ASX:HCW) suspended distributions while it works through the transfer of 10 Healthscope hospitals. Victor Group Holdings (ASX:VIG) reported a A$9.33 million loss and only A$924,828 in cash. Investors rewarded growth where it came with cash, but punished plans that still depend on another capital raising.
Bottom Line?
The next week will turn attention to shareholder votes, Court approvals, project financing and fresh drilling results. Bannerman’s Etango project still needs a Final Investment Decision, while Carnaby Resources’ shareholders will vote on Evolution Mining’s offer on 26 October. October assays from White Cliff Minerals and further drilling across several gold and copper projects may decide whether this week’s gains continue.
Questions in the middle?
- Will Bounty Oil secure a Liberian production contract before issuing the large number of proposed new shares?
- Can Waratah Minerals prove that its high-grade Spur intersections form a mineable resource?
- Will investors accept the dilution from Nyrada’s capital raising if its Xolatryp trial produces useful results?